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The Negative Sense RNA Hantavirus – A Threat to the 
Modern World
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Ab s t r Ac t
Hantaviruses are rodent-borne zoonotic pathogenic viruses that produce two major clinical syndromes in humans: Hemorrhagic fever with 
renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). These are negative sense RNA viruses. Each hantavirus type has a single 
predominant natural reservoir and is transmitted through aerosolized rodent excreta or rodent bites. Case fatality rates for HFRS can reach 
up to 15% and for HPS can exceed 40%. Very recently, the occurrence of hantavirus has been seen in China in March, 2020. This review 
summarizes the current knowledge on virology, epidemiology, clinical manifestation, laboratory diagnostics, treatment, and prevention of 
hantaviruses and hantaviral infections.
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In t r o d u c t I o n
Hantaviruses are distributed worldwide, but the distribution of 
specific virus type is needed to be further investigated.[1] Hantavirus 
is found in the urine, saliva, or droppings of infected deer mice and 
some other wild rodents. The virus does not remain active for long 
once come outside the host body usually <1 week and few hours 
when exposed to direct sunlight (www.cdc.gov/hantavirus).
Hantaviruses belong to the Bunyaviridae family of viruses 
that are divided into five genera: Orthobunyavirus, Nairovirus, 
Phlebovirus, Tospovirus, and Hantavirus. The members of this 
family have genomes comprised three negative-sense, single-
stranded RNA segments, and hence are classified as negative 
sense RNA viruses. Viruses in the genus hantavirus are unique 
in their transmittance by aerosolized rodent excreta or rodent 
bites, whereas all other genera in the family are arthropod-
borne viruses.[2]
The name hantavirus is derived from the Hantan River, where 
the hantavirus (the etiologic agent of Korean hemorrhagic fever 
[KHF]) was first isolated by Dr. Ho-Wang Lee et al. The disease 
associated with hantavirus is called hemorrhagic fever with renal 
syndrome (HFRS) and was formerly known as KHF, or epidemic 
hemorrhagic fever (EHF), or nephropathia epidemica (NE).[3] On 
the basis of phylogenetic origin hantaviruses are divided in two 
categories: Old world hantavirus causing HFRS and new world 
hantavirus causing hantavirus pulmonary syndrome (HPS).[4] The 
former one consists of four species of hantavirus and the second 
one consists of the remaining (almost 24).
HI s to ry
The hantaviruses constitute a relatively newly discovered genus 
of viruses; HFRS was first recognized by western medicine during 
the Korean War in the early 1950s. In 1993, a newly-recognized 
species of hantavirus was found as a causative agent of hantavirus 
cardiopulmonary syndrome (HCPS, also called HPS) caused by the 
Sin Nombre virus (SNV) (Spanish for “nameless virus”) in New Mexico 
and other four corners of the states. In addition to hantavirus and 
SNV, several other hantaviruses have been implicated as etiologic 
agents for either HFRS or HCPS.[5]
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The “first” outbreak of HPS
In May 1993, an outbreak of an unexplained pulmonary illness 
occurred in the Southwestern United States, in an area shared 
by Arizona, New Mexico, Colorado, and Utah known as “The 
Four Corners.” A young, physically fit Navajo man suffering from 
shortness of breath was rushed to a hospital in New Mexico 
and died very rapidly. While reviewing the results of the case, 
medical personnel discovered that the young man’s fiancee had 
died few days before after showing similar symptoms, a piece of 
information that proved key to discovering the disease. As Dr. 
James Cheek of the Indian Health Service (IHS) noted, “I think 
if it hadn’t been for that initial pair of people that became sick 
within a week of each other, we never would have discovered the 
illness at all.” An investigation combing the entire Four Corners 
region was launched by the New Mexico Office of Medical 
Investigations (OMI) to find out the similar case history. During 
this investigation, Dr. Bruce working with OMI had located five 
young, healthy people who died after acute respiratory failure. A 
series of laboratory tests had failed to identify any of the deaths 
as caused by a known disease. At this point, the Centers for 
Disease Control and Prevention (CDC) Special Pathogens Branch 
was notified and CDC, the state health departments of New 
Mexico, Colorado, and Utah, the IHS, the Navajo Nation, and the 
Keshani and S. S. Kanwar: The Sin Nombre hantavirus www.apjhs.com
Asian Pacific Journal of Health Sciences | Vol. 7 | Issue 2 | April-June | 2020 43
University of New Mexico all were joined together to confront 
the outbreak.
The particular mixture of symptoms and clinical findings 
pointed researchers toward some type of virus. Samples of tissue 
from patients who had gotten the disease were sent to CDC for 
analysis. Virologists at CDC after examining the samples linked the 
pulmonary syndrome with an unknown type of hantavirus (http://
www.cdc.gov/hantavirus/surveillance/index.html).
The carrier of this unknown hantavirus was found to be 
rodents with deer mouse (Peromyscus maniculatus) as the most 
prevalent host.[2] Since the deer mouse often lives near human 
communities, researchers suspected that the deer mouse might 
be transmitting the virus to the humans. In November 1993, the 
specific hantavirus that caused the Four Corners outbreak was 
isolated. This new virus was called Muerto Canyon virus, which was 
later changed to SNV and the new disease caused by the virus was 
named as hantavirus pulmonary syndrome, or HPS.[6,7]
There is a recent case reported in China in March 2020, 
where a man died in bus tested positive for hantavirus infection. 
“The unidentified victim from Yunnan Province died while on a 
chartered bus heading to his workplace in Shandong Province, the 
state-run Global Times announced in a tweet.” (nypost.com)
re s e r vo I r Ho s ts
The main hosts of hantaviruses are rodents (www.cdc.gov/
rodents):
1. The deer mouse (P. maniculatus) is a deceptively cute animal, 
with big eyes and big ears. Its head and body are normally 
about 2–3″ long, and the tail adds another 2–3″ in length. You 
may see it in a variety of colors, from gray to reddish brown, 
depending on its age. The underbelly is always white and the 
tail has sharply defined white sides. The deer mouse is found 
almost everywhere in North America. Usually, the deer mouse 
likes woodlands, but also turns up in desert areas.
2. The cotton rat (Sigmodon hispidus), found in the Southeastern 
United States, has a bigger body than the deer mouse. It has 
head and body about 5–7″ long, and another 3–4″ for the tail. 
The hair is longer and coarser, of a grayish-brown color, even 
grayish-black. The cotton rat prefers overgrown areas with 
shrubs and tall grasses.
3. The white-footed mouse (Peromyscus leucopus) is hard to 
distinguish from the deer mouse. The head and body together 
are about 4″ long. Its tail is normally shorter than its body 
(about 2–4″ long). Its upper side fur ranges from pale-brown 
to reddish-brown, while its underside and feet are white. The 
white-footed mouse is found through Southern New England, 
the Mid-Atlantic and Southern States, the Midwestern and 
Western States, and Mexico. It prefers wooded and brushy 
areas, although sometimes it lives in open grounds.
4. The rice rat (Oryzomys palustris) is slightly smaller than the 
cotton rat, having a head and body 5–6″ long with a 4–7″ 
long tail. Rice rat has short, soft, grayish-brown fur on top, 
and gray or tawny underbellies. Their feet are whitish. The 
rat likes marshy areas and is semiaquatic. It is found in the 
southeastern United States and in Central America.
5. The striped field mouse (Apodemus agrarius) is a rodent in 
the family Muridae. The range of this species stretches from 
Eastern Europe to Eastern Asia. The upper parts of the mouse 
are grayish brown with a rusty tint with a prominent mid-
dorsal black stripe. The under parts are paler and grayish. The 
ears and eyes are relatively small. The body length reaches 5″, 
with a tail of up to 3.5″, and it weighs up to 50 g. It inhabits 
a wide range of habitats including the edges of woodlands, 
grasslands, marshes, pastures, gardens, and urban areas.
Each hantavirus type has a single predominant natural reservoir. 
Usually, the phylogenetic interrelationships among the viruses and 
those of their predominant host show remarkable concordance. 
The time and space distribution of hantavirus infection reflects the 
distribution and variation of their rodent hosts.[8,9]
vI r o lo g y
Virion Properties
The virion is spherical or oval-shaped with 80–120 nm in 
diameter.[10-12] It has unique grid-like surface pattern, with 
7–8 nm projections.[13,14] It has lipid bilayer envelope with granulo-
filamentous interior.[15] It can survive for 12 h at 4°C, high salt 
concentration and non-physiological pH and even survives for 
1–3 days after drying. However, exposure to heat, UV irradiation, 
hypochlorite solutions, lipid solvents, and nonionic detergents 
destroys the viral envelope.[16]
Genome
Like other members of the Bunyaviridae family, hantaviruses are 
enveloped viruses with a genome that consists of three single-
stranded, negative sense RNA segments designated as S (small), 
M (medium), and L (large).[2,17] The S RNA (1.7-2.1kb) encodes 
the nucleocapsid (N) protein. The M RNA (3.6-3.7kb) encodes a 
polyprotein that is cotranslationally cleaved to yield the envelope 
glycoproteins G1 and G2. The L RNA (6.5 kb) encodes the L protein, 
which acts as the viral transcriptase/replicase.[18,19] Within virions, 
the genomic RNAs of hantaviruses are complex with the N protein 
to form helical nucleocapsids, the RNA component of which 
circularizes due to sequence complementarity between the 5’ and 
3’ terminal sequences of genomic segments.
Entry into host cells is thought to occur by attachment 
of virions to cellular receptors and their subsequent 
endocytosis. Nucleocapsids are introduced into the cytoplasm 
by pH-dependent fusion of the virion with the endosomal 
membrane. Transcription of viral genes is initiated by association 
of the L protein with nucleocapsids. The viral L protein is thought 
to have an endonuclease activity that cleaves cellular mRNAs for 
the production of capped primers used to initiate transcription 
of viral mRNAs. As a result of this “cap snatching,” the mRNAs of 
hantaviruses are capped and contain non-templated 5’ terminal 
extensions. The glycoproteins (G1 and G2) after forming hetero-
oligomers are transported to golgi complex. The L protein produces 
nascent genomes through replication by a positive-sense RNA 
intermediate. Hantavirus virions are assembled by association of 
nucleocapsids with glycoproteins embedded in the membranes of 
the Golgi, followed by budding into the Golgi cisternae. Nascent 
virions are then transported in secretory vesicles to plasma 
membrane and then released by exocytosis.[15,20-26]
Properties of components involved
Integral membrane glycoproteins, namely, MeG1 and G2 (highly 
conserved) weigh 64–67 kDa and 54 kDa, respectively. The G1-G2 
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heterodimers form 8 nm projections on virion surface. These are 
cysteine-rich and contain asparagine-linked sugar groups. The 
proteins play an important role in cell entry and pathogenesis. 
Nucleocapsid protein N weighs 48 kDA and complexes with 
genomic vRNA as well as with cRNA after infection, but not 
with mRNA. It is necessary for virus replication and packaging. 
Polymerase L weighs 247 kDA. It is a RNA-dependent RNA 
polymerase (RdRp) and complexed with ribonucleocapsids 
in virion. It has endonuclease activity to cleave host mRNA, 
transcriptase activity for making cRNA and mRNA from vRNA and 
helicase activity to unwind vRNA during transcription.[27-31]
Transcription
Viral polymerase transcribes negative-strand vRNA to mRNA. 
Polymerase acts as endonuclease and cleaves host mRNAs about 
7–18 nucleotides from the 5’ cap. The capped oligonucleotides act 
as primers required to initiate transcription. After transcription is 
primed and the first repeat of the terminal sequence is transcribed, 
polymerase slips and realigns the nascent RNA and then continues 
transcription.
Replication
Viral polymerase transcribes antisense vRNA to sense cRNA. cRNA 
is used as template to make more negative-strand vRNA. pppG is 
used to prime cRNA and vRNA synthesis using the same “prime 
and realign” strategy.
Complete Replication Cycle
For attachment viral G1 and G2 glycoproteins interact with cell 
surface receptors. Pathogenic hantaviruses bind b3 integrins and 
non-pathogenic hantaviruses bind b1 receptors. Virus particles 
bound to integrin receptors are taken in by receptor mediated 
endocytosis.[32] Newly formed vesicles are acidified. Acidic 
environment changes conformation of G1 and G2 glycoproteins. 
Viral and cell membrane fuse releasing genomic material and 
polymerase into the cytoplasm.
After this, primary transcription occurs that transcribes 
negative sense vRNA to mRNA. Viral polymerase (RdRp) transcribes 
nucleoprotein-coated vRNA. Capped oligonucleotides from 
cell’s own mRNA are used to prime transcription that follows the 
“prime and realign” model. L and S segment mRNA is translated 
on free ribosomes in cytoplasm. M segment mRNA translated on 
ER-bound ribosomes. G1 and G2 peptides produced from M mRNA 
are cleaved cotranslationally. Separate signal sequences for G1 and 
G2 cause ER attachment and embed the peptides in ER membrane 
(Signal Hypothesis).
During replication vRNA is used as a template by viral 
polymerase to make sense strand cRNA. cRNA is used as a template 
to make more negative strand vRNA. Extra vRNA synthesized 
during replication is used as template to make mRNA during 
secondary transcription. Since more template is present after 
vRNA is replicated, more mRNA can be transcribed, and more viral 
proteins can be made.
In the course of virion assembly, membrane-bound G1 and G2 
peptides are transported to Golgi and carbohydrates are attached 
by N-linked glycosylation. vRNA complexes with N nucleopcapsid 
protein, forms looped panhandle structure, and complexes 
with L polymerase. Nucleocapsid complexes bud into the Golgi 
membrane with G1 and G2 embedded and virion particle is 
formed inside the Golgi. Virions are transported to cell membrane 
by vesicles and released by exocytosis. Viruses may prefer different 
cell surfaces for release.
PAt H o g e n e s I s
Hantavirus infection is more prominent in males as compare to 
females, with a M:F ratio of 2:1–3:1, with most of the cases occurring 
within the 20–40 age group. The pathogenesis of hantavirus 
infections is unclear. The primary replication site is not clear, in both 
HFRS and HPS, but the main effect is observed in blood vessels. It 
has been demonstrated that some pathogenic hantavirus enters 
cells through beta-3 integrins, which are present on the surfaces 
of endothelial cells, macrophages, and platelets;[32,33] however, 
a study showed that beta-3 integrins did not play an essential 
role for respiratory epithelial cell monolayer integrity.[34] There is 
increased vascular permeability and decreased blood pressure 
due to endothelial dysfunction. The hallmark feature of hantaviral 
infections is capillary leak. In HFRS, the maximum damage occurs 
in kidneys, and in HPS, lungs and spleen are most affected parts.
Hantavirus and Host Cells
Virus replication usually stops host macromolecule synthesis; 
however, hantavirus replication does not affect host cell’s natural 
functions and moreover, hantavirus release does not require host 
cell lysis. Hantavirus is able to establish a persistent infection in 
rodent host cells.[1]
Laboratory Diagnosis of Hantavirus
Hantavirus is difficult to culture, so morphological identification is 
difficult. The most practical approach for the laboratory diagnosis 
of hantavirus infection is based on serologic tests.[35,36] The three 
structural proteins of hantaviruses (Gn, Gc, and N) can induce a 
high level of IgM antibodies, which are detectable at the onset 
of symptoms.[37] The plaque reduction neutralization test is 
considered to be most effective serological test and it can be used 
to discriminate between different species of hantavirus. An reverse 
transcription-polymerase chain reaction (PCR) using primers for 
conserved genome regions also allows confirmation of infection. 
PCR product can be sequenced and compared to known viral 
sequence database for species identification.
Hantavirus Pulmonary Syndrome/HPS
It is mostly found in North and South America. This disease is 
characterized by symptoms that resemble the flu, followed by 
respiratory failure and is not contagious.[38]
Hantavirus has probably caused people to get sick for years 
in the United States, but it was not recognized until 1993 after 
an outbreak of fatal respiratory illness. Hantavirus is carried by 
rodents, particularly deer mice, and is present in their urine and 
feces. The virus does not cause disease in the carrier animal. 
Humans are thought to become infected when they are exposed 
to contaminated dust from the nests or droppings of mice.
The initial symptoms of HPS closely resemble the flu. The 
disease begins abruptly with fever, chills, muscle aches, headache, 
nausea, vomiting, and malaise. A dry cough may be present. After 
a day or two an increased respiratory rate caused by seepage of 
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fluid into the lungs occurs. The initial shortness of breath is subtle 
but progression is rapid. The clinical course of HPS is divided into 
three periods: The febrile prodrome, cardiopulmonary stage, and 
convalescence.
There is a 14–17-day incubation period after exposure 
followed by the prodrome phase typically lasting 3–6 days with 
myalgia, malaise, and fever of abrupt onset in the absence of 
cough and coryza. Other early symptoms include gastrointestinal 
disturbance, headache, and chills.
The febrile phase of SNV-induced HPS is followed by a 
cardiopulmonary phase characterized by acute onset of pulmonary 
edema. At this stage, cough is generally present, and gastrointestinal 
manifestations may dominate the clinical presentations.[39]
Tachypnea, tachycardia, and postural hypotension are typical, 
whereas chest examination is not impressive. Like HFRS, the most 
common hematologic abnormalities at the late phase of HPS 
are thrombocytopenia and leukocytosis. The patient ultimately 
develops respiratory failure.[40] An effective treatment for 
hantavirus is not yet available. Even with intensive therapy, more 
than half of the diagnosed cases have been fatal.
Hemorrhagic Fever with Renal Syndrome/HFRS
HFRS refers to a group of clinically similar diseases that occur 
throughout Europe and Asia. It includes several diseases that 
formerly had other names, including KHF, EHF, and NE.
During HFRS an incubation phase of 2–3 weeks followed by the 
onset of flu-like symptoms, lasting 3–5 days occurs. Hemorrhaging 
can occur during this time. Next is hypotensive phase that usually 
lasts from hours to days. Nausea and vomiting are common in this 
phase of the disease and about one-third of the patients die due 
to shock, and vascular leakage. Sometimes renal failure also occurs 
that is characterized as oliguric phase. However, in next phase, 
patients show improved renal functions and it takes about weeks 
to months for the complete recovery of patient, this final phase is 
known as convalescent phase.
These symptoms can be split into five phases:
• Febrile phase: This is the first phase lasting for 3–7 days. The 
symptoms include fever, chills, malaise, headaches, nausea, 
abdominal and back pain, respiratory, and gastrointestinal 
problems.
• Hypotensive phase: This phase can past for 2 days and occurs 
when the blood platelet level drops that lead to tachycardia 
and hypoxemia.
• Oliguric phase: This phase pasts for 3–7 days and is 
characterized by the onset of renal failure and proteinuria.
• Diuretic phase: This is characterized by diuresis of 3–6 L/day, 
which can last for a couple of days to weeks.
• Convalescent phase: In this phase, recovery occurs and 
symptoms begin to improve.
tr e At m e n t
There is no specific treatment or cure for hantavirus infection. 
Treatment of patients with HPS remains supportive in nature. 
Patients should receive appropriate, broad-spectrum antibiotic 
therapy while awaiting confirmation of HPS. Patients presenting 
with fulminant illness due to HPS have a poor prognosis despite 
ICU care. If there is high suspicion of HPS, patients should be 
immediately transferred to an emergency department for close 
monitoring and care. Fluids should be administered carefully 
due to the potential for capillary leakage. Supplemental oxygen 
should be administered if patients become hypoxic. Equipment 
and materials for intubation and mechanical ventilation should be 
readily available since onset of respiratory failure is usually fast.
Intravenous ribavirin, a guanosine analog, is not effective 
for the treatment of HPS though it is found effective for HFRS. 
Controlled trials showed a reduction in case-fatality for HFRS 
patients treated with ribavirin. However, ECMO – Extra Corporeal 
Membrane Oxygenation is used for HPS.[41]
Tests for the disease include
• CBC (will show elevated white blood count)
• Platelet count (will be <150,000 and decreasing)
• X-ray of the chest (will show material invading the lungs, 
involving both lungs)
• Liver enzymes (lactate dehydrogenase will be elevated)
• Serum albumin (levels will be decreased)
• Hematocrit (will be increased, showing an increase in the 
levels of red blood cells).
Pr e v e n t I o n
Rodent’s urine and feces exposure should be avoided. During 
hiking and camping, the tents should be pitched in areas without 
rodent droppings. Keeping a clean home diminishes the chances 
of contacting hantavirus by clearing out potential nesting sites 
and maintaining a clean kitchen.[42,43]
The recommendations of U.S. CDC must be followed:
1. While opening an unused cabin, shed, or building, all the 
doors and windows must be opened, and the space must be 
allowed to air out for 30 min.
2. After returning to the building, the surfaces, carpet, and other 
areas must be sprayed with a disinfectant and the building 
must be left for another additional 30 min.
3. Mouse nests and droppings should be sprayed with 10% 
solution of chlorine bleach or equivalent disinfectant, and 
allowed to sit for 30 min, using rubber gloves the material 
should be placed in plastic bags, sealed, and disposed of. The 
gloves and cleaning materials should also be disposed of in 
the same manner.
Vacuuming should be avoided until the area has been 
thoroughly decontaminated and should only be done (the first 
few times) with adequate ventilation.
bI ot e r r o r I s m
According to the U.S. CDC, bioterrorism is the deliberate release 
of viruses, bacteria, toxins, or other harmful agents to cause illness 
or death in people, animals, or plants.  Biological agents can be 
spread through air, water, or food; have specific latent time and 
are extremely difficult to detect. Under CDC classification HFRS 
causing strains are Category A because of high infectivity and 
morbidity. HPS causing strains are Category C because of low 
infectivity.
There are certain considerations of pathogens for use in 
bioterrorism which include: 
1. Health effects
a. HFRS has medium lethality however HPS is highly lethal
b. HFRS has some success with antiviral treatments whereas 
for HPS no effective treatment is available
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2. Epidemiology
a. Hantavirus takes medium incubation time to cause 
secondary infections
b. It has rodent as a vector and can spread through aerosols
3. Aerosolization
a. Virus can only be infectious for 1–3 days outside a host 
because of a weak lipid envelope
b. The number of particles needed to cause a human 
infection is not known
4. Cost effectiveness
 The resources would be required to successfully disseminate 
hantavirus in a large population:
a. Preparation of virus using cell culture
b. Aerosolization
c. Contaminated water
d. Creation of infected rodent population
5. Psychological effects
a. HFRS causes dramatic visual effects in patients
b. HPS would be especially difficult to diagnose outside of 
its normal range
c. Media coverage is as “super flu” or “hemorrhagic fever”
6. Economic impact
a. Treatment
b. Disruption of work
c. Hysteria.
Hantavirus can prove as a good terrorist weapon as there 
is no cure for HPS infection and there is fairly long incubation 
period between infection and onset of symptoms. It is difficult 
to diagnose HPS and it has high lethal rate. However, it has low 
infectivity, difficult production, and less stability.
vAcc I n e s
Vaccines against hantaviral infections have been used for years in 
China and the Republic of Korea.[44,45] Some of the used vaccines 
are:
a. Escherichia coli expressed truncated nucleocapsid as an 
immunogen
b. Naked DNA
c. Recombinant non-pathogenic virus
d. Rodent brain-derived
e. Cell culture derived
f. Inactivated virus.[46]
co n c lu s I o n
 With the advancing years the understanding and recognition of 
hantaviral infections through the world is increasing. Though 
newly detected, Hantavirus is an old disease.  These are negative 
sense RNA viruses with a rodent as a natural reservoir and are 
transmitted through their excreta or bites.  There is a long way 
to go to find an effective treatment for hantavirus infections. 
Prevention can be partially achieved by rodent avoidance, but real 
protection will require a safe and effective multivalent vaccine or a 
vaccine adapted to local conditions.
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